Clinical Trials in Shiyan, Hubei
6 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled497 locationsNCT06430801
Recruiting
Not Applicable
Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Glycemic Control and Cardiovascular Disease Risk in Patients With Type 2 Diabetes
Diabetes Mellitus, Type 2
Huazhong University of Science and Technology2,500 enrolled5 locationsNCT06861062
Recruiting
Not Applicable
A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
Renal Anemia of Chronic Kidney Disease
Guangdong Provincial People's Hospital96 enrolled24 locationsNCT07136792
Recruiting
Phase 3
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Covalent Bruton Tyrosine Kinase (BTK) Inhibitors
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
BeOne Medicines150 enrolled64 locationsNCT06970743
Recruiting
The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus
Cognitive Dysfunction
Tongji Hospital5,000 enrolled21 locationsNCT07128186
Recruiting
Phase 3
MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
Acute Myeloid Leukaemia
Zhongnan Hospital154 enrolled11 locationsNCT06345365